Valeant boosts offer for Botox maker Allergan

On Monday, Canadian drugmaker Valeant Pharmaceuticals International Inc. raised its offer for Allergan Inc. to $200 or more per share.

The Botox maker's shares jumped 2.7 percent in premarket trading on the news. Irvine-based Allergan employs 11,700 in more than 100 countries.

According to USA Today, Valeant has made several offers to buy Allergan, the latest amounting to about $179 per share at current stock values.

Read more from USA Today.